These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5384122)

  • 21. [Drug committees are not necessary--therapeutic recommendations are issued anyway].
    Jönsson B
    Lakartidningen; 2005 Jul 11-24; 102(28-29):2085-6: discussion 290-2. PubMed ID: 16097181
    [No Abstract]   [Full Text] [Related]  

  • 22. [Available list of adverse effects].
    Liljestrand A
    Lakartidningen; 1976 Apr; 73(15):1397. PubMed ID: 1263655
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug committee: committee is going to bring about a more knowledgeable attitude to the selection of drugs].
    Hagelsten JO
    Sygeplejersken; 1978 Mar; 78(12):4-7, 20. PubMed ID: 247708
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug committees' information leaflets are needed].
    Asberg KH
    Lakartidningen; 2009 Sep 16-22; 106(38):2384. PubMed ID: 19848349
    [No Abstract]   [Full Text] [Related]  

  • 25. [Local reporting of adverse effects--an experimental work at the main hospital].
    Hallberg L; Lundborg P
    Lakartidningen; 1974 May; 71(19):1916-7. PubMed ID: 4133506
    [No Abstract]   [Full Text] [Related]  

  • 26. Organization and operation of P & T Committees in the state of Florida: a survey.
    Hatton RC; Doering PL
    Hosp Formul; 1990 Sep; 25(9):983-6, 988-9. PubMed ID: 10106259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational drug use (II): Hospital drug and therapeutics committees.
    Manyemba J; Dzuda C; Nyazema NZ
    Cent Afr J Med; 2000 Sep; 46(9):256-9. PubMed ID: 11320773
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rational drug prescription: a question of knowledge and direction. Qualitative study at ten community health centers in the county of Stockholm].
    Jägestedt M; Ronge S; Wettermark B; Karlsson EA
    Lakartidningen; 2008 Oct 15-21; 105(42):2924-9. PubMed ID: 19025149
    [No Abstract]   [Full Text] [Related]  

  • 30. The Swedish Adverse Drug Reaction Committee: an important tool for safer drug therapy.
    Böttiger LE
    QRB Qual Rev Bull; 1981 Feb; 7(2):14-20. PubMed ID: 6785702
    [No Abstract]   [Full Text] [Related]  

  • 31. [What should embrace a national therapeutic drug strategy?].
    Furängen A; Cronlund A
    Lakartidningen; 2010 Jun 2-8; 107(22):1486-7; discussion 1487. PubMed ID: 20645603
    [No Abstract]   [Full Text] [Related]  

  • 32. [Radioactive drugs in Sweden].
    Aberg B
    Nord Med; 1971 Nov; 86(47):1387-8. PubMed ID: 5138078
    [No Abstract]   [Full Text] [Related]  

  • 33. Mission, role, and functions of the P & T Committee.
    Bell JE; Evans PJ; Standish RC
    Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.
    Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC
    Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug committees towards the regions. The Danish Society of Clinical Pharmacology].
    Reuther LØ; Brock B;
    Ugeskr Laeger; 2007 Mar; 169(12):1113. PubMed ID: 17394824
    [No Abstract]   [Full Text] [Related]  

  • 37. Developing policy for handling investigational drugs.
    Ebel JA
    Hosp Manage; 1967 Aug; 104(2):58-64. PubMed ID: 6073958
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of drug and therapeutics committee towards drug safety--experiences from western Nepal.
    Palaian S; Mishra P
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):79-80. PubMed ID: 16401950
    [No Abstract]   [Full Text] [Related]  

  • 39. [The drug committee at an ordinary hospital--is it capable of anything?].
    Bergfors PG; Ogren JE
    Lakartidningen; 1974 Jul; 71(27):2658-9. PubMed ID: 4839608
    [No Abstract]   [Full Text] [Related]  

  • 40. [The DU90% is a new quality measure for drug prescription. Non-steroidal anti-inflammatory agents as an example for analysis].
    Bergman U; Wettermark B; Myrhed M; Arrhenius L
    Lakartidningen; 1998 Sep; 95(39):4237-8, 4241-2. PubMed ID: 9785772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.